42
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Subjective Clinical Lipoatrophy Assessment Correlates with DEXA-Measured Limb Fat

, , , , , , & show all
Pages 314-319 | Published online: 06 Jan 2015

REFERENCES

  • Carr A, Samaras K, Burton S, et al. A syndrome of periph-eral lipodystrophy, hyperlipidaemia and insulin resis-tance in patients receiving HIV protease inhibitors. AIDS. 1998;12(7):F51–58.
  • Hatano H, Miller KD, Yoder CP, et al. Metabolic and anthro-pometric consequences of interruption of highly active antiretroviral therapy. AIDS. 2000;14(13):1935–1942.
  • Miller KD, Jones E, Yanovski JA, Shankar R, Feuerstein I, Falloon J. Visceral abdominal-fat accumulation asso-ciated with use of indinavir. Lancet. 1998;351(9106): 871–875.
  • Carr A, Workman C, Smith DE, et al. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial. JAMA. 2002;288(2):207–215.
  • Dukers NH, Stolte IG, Albrecht N, Coutinho RA, de Wit JB. The impact of experiencing lipodystrophy on the sexual behaviour and well-being among HIV-infected homosexual men. AIDS. 2001;15(6):812–813.
  • Duran S, Saves M, Spire B, et al. Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy. AIDS. 2001;15(18):2441–2444.
  • McComsey GA, Ward DJ, Hessenthaler SM, et al. Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study. Clin Infect Dis. 2004;38(2):263–270.
  • Mulligan K, Tai VW, Algren H, et al. Altered fat distribution in HIV-positive men on nucleoside analog reverse tran-scriptase inhibitor therapy. J Acquir Immune Defic Syndr 2001 ;26(5):443–448.
  • Melial SA, John M, Moore CB, James IR, McKinnon EJ. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS. 2000;14(10):1309–1316.
  • Prior BM, Cureton KJ, Modlesky CM, et al. In vivo validation of whole body composition estimates from dual-energy X-ray absorptiometry. J Appl Physiol. 1997;83(2):623–630.
  • Salamone LM, Fuerst T, Visser M, et al. Measurement of fat mass using DEXA: a validation study in elderly adults. J Appl Physiol. 2000;89(1):345–352.
  • McComsey GA, Paulsen DM, Lonergan JT, et al. Improve-ments in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zido-vudine. AIDS. 2005;19(1):15–23.
  • Shikuma CM, Hu N, Milne C, et al. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy. AIDS. 2001;15(14):1801–1809.
  • Hoy JF, Gahan ME, Carr A, et al. Changes in mitochondrial DNA in peripheral blood mononuclear cells from HIV-infected patients with lipoatrophy randomized to receive abacavir. J Infect Dis. 2004;190(4):688–692.
  • Carr A, Law M. An objective lipodystrophy severity grad-ing scale derived from the lipodystrophy case definition score. J Acquir Immune Defic Syndr 2003;33(5):571–576.
  • Podzamczer D, Ferrer E, Martinez E, Team AS. How much fat loss is needed for lipoatrophy to become clinically evident? Paper presented at: 15th Conference on Retro-viruses and Opportunistic Infections; February 3–6, 2008; Boston. MA. Abstract 941.
  • Shiramizu B, Shikuma KM, Kamemoto L, et al. Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibi-tors during pregnancy. J Acquir Immune Defic Syndr. 2003;32(4):370–374.
  • Funk E, Brissett AE, Friedman CD, Bressler FJ. HIV-associated facial lipoatrophy: establishment of a validated grading scale. Laryngoscope. 2007;117(8):1349–1353.
  • Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol. 2005;52(2):233–239.
  • Bacchetti P, Gripshover B, Grunfeld C, et al. Fat distribu-tion in men with HIV infection. J Acquir Immune Defic Syndr 2005;40(2):121–131.
  • Gerschenson M, Shiramizu B, LiButti DE, Shikuma CM. Mitochondrial DNA levels of peripheral blood mononuclear cells and subcutaneous adipose tissue from thigh, fat and abdomen of HIV-1 seropositive and negative individuals. Antivir Ther 2005;10(Suppl 2):M83–89.
  • McComsey GA, O'Riordan M, Setzer B, Lebrecht D, Baron E, Walker UA. Uridine supplementation in HIV lipoatrophy: pilot trial on safety and effect on mitochondrial indices. Eur J Clin Nutr 2007:1031.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.